Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Artificial Intelligence (AI) In Predictive Toxicology Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The market size for artificial intelligence (AI) in predictive toxicology has seen rapid expansion over recent years. It is projected to increase from $0.64 billion in 2025 to $0.83 billion in 2026, achieving a compound annual growth rate (CAGR) of 29.3%. The growth witnessed in the past can be ascribed to a growing demand for safer chemicals, increasing pharmaceutical research and development, rising regulatory pressure for chemical safety, early adoption of computational toxicology, and advancements in bioinformatics tools.
The artificial intelligence (ai) in predictive toxicology market is anticipated to experience substantial growth over the coming years. Its valuation is projected to reach $2.29 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 28.9%. This expansion during the projection period is primarily driven by factors such as the increasing integration of AI-powered predictive models, the proliferation of cloud-based platforms for toxicology, the synthesis of genomic and chemical data, enhanced partnerships between pharmaceutical and biotechnology firms, and a surging requirement for swift chemical safety evaluations. Key developments expected within the forecast timeframe encompass the merging of multi-omics data for predicting toxicity, computational drug toxicity modeling, efficient high-throughput toxicological screening, AI-guided chemical prioritization, and cloud-centric management of toxicology data.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence (AI) In Predictive Toxicology Market Industry Drivers: What’s Behind The Revenue Growth?
The growing requirement for effective and ethical drug discovery methodologies is expected to drive the expansion of the artificial intelligence (AI) in predictive toxicology market moving forward. Drug discovery is an elaborate and evolving procedure encompassing the systematic investigation, synthesis, and evaluation of chemical compounds to identify potential therapeutic agents for disease alleviation and overall well-being. Efficient and ethical drug discovery processes involve utilizing advanced technologies and prioritizing responsible research practices to develop new treatments. This increasing demand for streamlined and ethical drug discovery is fueled by the rise in chronic illnesses, the expanding trend toward personalized medicine, and a higher incidence of age-related diseases. Artificial intelligence (AI) in predictive toxicology enhances drug discovery by efficiently analyzing extensive datasets to forecast potential toxicological outcomes, thereby accelerating drug development while ensuring ethical criteria are met. For instance, in 2023, the UK government’s net spending on research and development (R&D) increased to £17.4 ($22.1 billion) billion, up from £16.1 billion ($20.45 billion) in 2022, marking an 8.2% rise, as reported by the Office for National Statistics, a UK-based government agency. Consequently, the rising demand for efficient and ethical drug discovery processes is propelling the growth of the artificial intelligence (AI) in predictive toxicology market.
Artificial Intelligence (AI) In Predictive Toxicology Market Segment Performance And Emerging Opportunities
The artificial intelligence (ai) in predictive toxicology market covered in this report is segmented –
1) By Component: Solution, Services
2) By Technology: Machine Learning, Other Technologies
3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints
4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users
Subsegments:
1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems
2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services
#Artificial Intelligence (AI) In Predictive Toxicology Market Growth Trends: What’s Shaping The Future Outlook?
Leading firms operating in the artificial intelligence (AI) predictive toxicology market are employing strategic partnership approaches to bolster their market presence and drive innovation. These collaborations are designed to leverage AI and machine learning techniques for enhanced prediction and assessment of the toxicity of chemical compounds and pharmaceuticals. For instance, in January 2024, SyntheticGestalt, a UK-based AI research and development company offering AI drug discovery solutions, partnered with Enamine, a Ukraine-based provider of chemical building blocks, screening compounds, and integrated drug discovery services, to develop a set of AI models. These models aim to facilitate the generation of synthetically accessible biologically active compounds while optimizing their physicochemical and ADME or Tox (Absorption, Distribution, Metabolism, and Excretion or Toxicity) properties. These new models will be applied in SyntheticGestalt’s compound discovery endeavors, serving both academic users and pharmaceutical companies through their services. Enamine has made its extensive Enamine REAL database, containing 38 billion molecules, available for access. SyntheticGestalt will integrate this database into its Drug Discovery Service, utilizing proprietary AI models to predict the physicochemical and ADME or Tox properties of compounds. The service will promptly suggest improved alternative compounds for those with issues.
Artificial Intelligence (AI) In Predictive Toxicology Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the artificial intelligence (ai) in predictive toxicology market are Certara Inc, Schrödinger Inc, Instem plc, Simulations Plus Inc, Lhasa Limited, Chemaxon Ltd, Algorithme Pharma, Benevolent AI, Berg Health, Biovista Inc, Recursion Pharmaceuticals Inc, Exscientia plc, Insilico Medicine Inc, Celsius Therapeutics Inc, ArisGlobal, Merative L.P., BioTeam Inc, Leadscope Inc, MultiCASE Inc, ACD Labs, Optibrium Ltd, Chemotargets SL, Toxys BV
View The Full Artificial Intelligence (AI) In Predictive Toxicology Market Report:
Artificial Intelligence (AI) In Predictive Toxicology Market Regional Analysis And Top Geography
North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in predictive toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model